Monogram Orthopaedics, Inc. (NASDAQ: MGRM) observed a surge in its stock value on the US market indices yesterday, marking a remarkable uptick of 79.30% and culminating at $4.07 by the close of trading. This surge was precipitated by the company’s embrace of a significant initiative.
Monogram Orthopaedics (MGRM) disclosed its partnership with NVIDIA Inception, a specialized program crafted to expedite the progress of enterprises through cutting-edge technologies and access to NVIDIA’s latest technical resources.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The collaboration with NVIDIA Inception is poised to propel Monogram Orthopaedics towards the advancement of its mBôs robotic surgical apparatus and associated software, orthopedic implants, tissue ablation instruments, navigation consumables, and assorted instrumentation requisite for reconstructive joint replacement surgeries.
This endeavor will be supplemented with comprehensive go-to-market support, expert guidance, and technological aid. Additionally, the program will furnish Monogram Orthopaedics with access to superior technical tools, contemporary resources, as well as avenues for investor engagement and collaboration with esteemed industry professionals and other AI-driven entities.
Monogram Orthopaedics is slated to be among the esteemed cohort of enterprises participating in the NVIDIA Inception program, thereby gaining access to premier hardware, cutting-edge resources, and avenues to fortify pioneering orthopedic robotics technology.
The strategic partnership with NVIDIA will equip Monogram Orthopaedics with supplemental resources, encompassing NVIDIA’s domain expertise and technological offerings, alongside go-to-market assistance such as industry introductions and co-marketing endeavors facilitated through NVIDIA’s expansive marketing network.
NVIDIA Inception serves as a nurturing ground for avant-garde AI startups that are reshaping industries. This preeminent virtual accelerator extends tailored go-to-market support, expert guidance, and technological resources, each calibrated to suit the developmental stage of nascent businesses.
With a membership tally exceeding 5,000, NVIDIA Inception champions select, nimble startups that are spearheading innovation and redefining conventional approaches to industry challenges through the application of AI.
The Inception program is poised to propel the Monogram Orthopaedics’ product launch for mBôs and foster the ongoing development of its next-generation product pipeline. Collaborating with the NVIDIA Inception team, Monogram Orthopaedics is committed to executing its commercialization roadmap with agility, aiming to secure FDA clearance expediently and cost-effectively.
